Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone).

被引:0
|
作者
Cornish, Elisa Eleanor [1 ,2 ]
Teo, Kelvin Yi Chong [1 ,3 ]
Gillies, Mark C. [1 ,2 ]
Lim, Lyndell L. [4 ]
McAllister, Ian [5 ]
Sanmugasundram, Sutha [4 ]
Vuong Nguyen [2 ]
Wickremasinghe, Sanjeewa [4 ]
Mehta, Hemal [6 ]
Fraser-Bell, Samantha [1 ,2 ]
机构
[1] Sydney Eye Hosp, Ophthalmol, Sydney, NSW, Australia
[2] Univ Sydney, Sydney Med Sch, Save Sight & Eye Hlth Inst, Sydney, NSW, Australia
[3] Singapore Natl Eye Ctr, Singapore, Singapore
[4] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia
[5] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA, Australia
[6] Royal Free London NHS Fdn Trust, Ophthalmol, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
4847
引用
收藏
页数:2
相关论文
共 50 条
  • [41] TWO-YEAR RESULTS OF A RANDOMIZED TRIAL OF INTRAVITREAL BEVACIZUMAB ALONE OR COMBINED WITH TRIAMCINOLONE VERSUS LASER IN DIABETIC MACULAR EDEMA
    Soheilian, Masoud
    Garfami, Kiumars Heidari
    Ramezani, Alireza
    Yaseri, Mehdi
    Peyman, Gholam A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (02): : 314 - 321
  • [42] Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial
    Mehta, Hemal
    Fraser-Bell, Samantha
    Yeung, Aaron
    Campain, Anna
    Lim, Lyndell L.
    Quin, Godfrey J.
    McAllister, Ian L.
    Keane, Pearse A.
    Gillies, Mark C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (07) : 1000 - 1004
  • [43] A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
    Alfredo Pece
    Paolo Milani
    Carla Monteleone
    Costantino John Trombetta
    Giuseppe De Crecchio
    Giuseppe Fasolino
    Domenica Matranga
    Salvatore Cillino
    Maria Vadalà
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 1867 - 1872
  • [44] A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
    Pece, Alfredo
    Milani, Paolo
    Monteleone, Carla
    Trombetta, Costantino John
    De Crecchio, Giuseppe
    Fasolino, Giuseppe
    Matranga, Domenica
    Cillino, Salvatore
    Vadala, Maria
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (11) : 1867 - 1872
  • [45] A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
    Tan, Colin S.
    Cheong, Kai Xiong
    Lim, Louis W.
    Tan, Shoun
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (07) : 1433 - 1434
  • [46] A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
    Colin S. Tan
    Kai Xiong Cheong
    Louis W. Lim
    Shoun Tan
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 1433 - 1434
  • [47] A Prospective, Randomized Comparison of Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab (Avastin) in Diffuse Diabetic Macular Edema
    Shahin, Maha M.
    El-Lakkany, Rasheed S.
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2010, 17 (03) : 250 - 253
  • [48] Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial
    Pearson, P. Andrew
    Comstock, Timothy L.
    Ip, Michael
    Callanan, David
    Morse, Lawrence S.
    Ashton, Paul
    Levy, Brian
    Mann, Eric S.
    Eliott, Dean
    OPHTHALMOLOGY, 2011, 118 (08) : 1580 - 1587
  • [49] Clinical factors associated with response to dexamethasone intravitreal implant in DME recalcitrant to bevacizumab
    Prasad, Pradeep
    Lee, Diana
    Javaheri, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [50] Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial
    Mishra, Sanjay Kumar
    Sinha, Shruti
    Chauhan, Ravi
    Kumar, Ashok
    CURRENT DRUG DELIVERY, 2021, 18 (06) : 825 - 832